Exact Mass: 285.1188

Exact Mass Matches: 285.1188

Found 73 metabolites which its exact mass value is equals to given mass value 285.1188, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

dimethylidenebutanedioylcarnitine

3-[(3-carboxy-2,3-dimethylidenepropanoyl)oxy]-4-(trimethylazaniumyl)butanoate

C13H19NO6 (285.1212)


dimethylidenebutanedioylcarnitine is an acylcarnitine. More specifically, it is an dimethylidenebutanedioic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. dimethylidenebutanedioylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine dimethylidenebutanedioylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

(2E,4E)-Hexa-2,4-dienedioylcarnitine

3-[(5-carboxypenta-2,4-dienoyl)oxy]-4-(trimethylazaniumyl)butanoate

C13H19NO6 (285.1212)


(2E,4E)-hexa-2,4-dienedioylcarnitine is an acylcarnitine. More specifically, it is an (2E,4E)-hexa-2,4-dienedioic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. (2E,4E)-hexa-2,4-dienedioylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine (2E,4E)-hexa-2,4-dienedioylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

3-Carbamyl-(3'-picolyl)-4-methoxy-1-benzamide

6-methoxy-N1-[(pyridin-3-yl)methyl]benzene-1,3-dicarboxamide

C15H15N3O3 (285.1113)


   

2-(3-(Diallylamino)propionyl)benzothiophene

1-(1-benzothiophen-2-yl)-3-[bis(prop-2-en-1-yl)amino]propan-1-one

C17H19NOS (285.1187)


   

Isoeudistomin U

Isoeudistomin U

C19H15N3 (285.1266)


   

(2-Methyl-1H-indol-3-yl)(naphthalen-1-yl)methanone

(2-Methyl-1H-indol-3-yl)(naphthalen-1-yl)methanone

C20H15NO (285.1154)


   

Mycosporine 2

Mycosporine 2

C13H19NO6 (285.1212)


   

2,4-dimethyl-3-pyrrolylcarbonyl alpha-L-rhamnopyranoside

2,4-dimethyl-3-pyrrolylcarbonyl alpha-L-rhamnopyranoside

C13H19NO6 (285.1212)


   

2,5-Dioxo-3-isopropyl-1H-pyrrole-1-propanoic acid 2,3-dihydroxypropyl ester

2,5-Dioxo-3-isopropyl-1H-pyrrole-1-propanoic acid 2,3-dihydroxypropyl ester

C13H19NO6 (285.1212)


   

iteamine|o-aminobenzyl beta-D-glucopyranoside

iteamine|o-aminobenzyl beta-D-glucopyranoside

C13H19NO6 (285.1212)


   

1-Pyridylhydroxybutyl-hypoxanthine

1-Pyridylhydroxybutyl-hypoxanthine

C14H15N5O2 (285.1226)


   

Tritylazide

Tritylazide

C19H15N3 (285.1266)


   

9-Benzyl-9H-carbazole-3-carbaldehyde

9-Benzyl-9H-carbazole-3-carbaldehyde

C20H15NO (285.1154)


   

4-MORPHOLIN-4-YL-2-PHENYL-BUTYRIC ACID HCL

4-MORPHOLIN-4-YL-2-PHENYL-BUTYRIC ACID HCL

C14H20ClNO3 (285.1132)


   

4-Pyridinecarboxylicacid, 2-[(3,4-dimethoxyphenyl)methylene]hydrazide

4-Pyridinecarboxylicacid, 2-[(3,4-dimethoxyphenyl)methylene]hydrazide

C15H15N3O3 (285.1113)


   

Methyl 2-[4-(4-piperidinyloxy)phenyl]acetatehydrochloride

Methyl 2-[4-(4-piperidinyloxy)phenyl]acetatehydrochloride

C14H20ClNO3 (285.1132)


   

Benzoctamine Hydrochloride

Benzoctamine Hydrochloride

C18H20ClN (285.1284)


   

3-(5-methoxy-6,7,8,9-tetrahydroimidazo[1,2-a]quinazolin-2-yl)-5-methyl-1,2,4-oxadiazole

3-(5-methoxy-6,7,8,9-tetrahydroimidazo[1,2-a]quinazolin-2-yl)-5-methyl-1,2,4-oxadiazole

C14H15N5O2 (285.1226)


   

3-(Boc-amino)-3-(3-chlorophenyl)-1-propanol

3-(Boc-amino)-3-(3-chlorophenyl)-1-propanol

C14H20ClNO3 (285.1132)


   

(S)-4-Benzyl-3-(4-fluorophenyl)morpholin-2-one

(S)-4-Benzyl-3-(4-fluorophenyl)morpholin-2-one

C17H16FNO2 (285.1165)


   

ethyltrimethylplumbane

ethyltrimethylplumbane

C5H17Pb (285.1097)


   

5-Deoxy-5-fluoro-2,3-O-isopropylidene-D-cytidine

5-Deoxy-5-fluoro-2,3-O-isopropylidene-D-cytidine

C12H16FN3O4 (285.1125)


   

2,3,4,5-Tetrahydro-3-(trifluoroacetyl)-1,5-methano-1H-3-benzazepine-7,8-diamine

2,3,4,5-Tetrahydro-3-(trifluoroacetyl)-1,5-methano-1H-3-benzazepine-7,8-diamine

C13H14F3N3O (285.1089)


   

(4-((((Benzyloxy)carbonyl)amino)methyl)phenyl)boronic acid

(4-((((Benzyloxy)carbonyl)amino)methyl)phenyl)boronic acid

C15H16BNO4 (285.1172)


   

1-FURAN-2-YL-2-[2-(2-HYDROXY-ETHYLAMINO)-BENZOIMIDAZOL-1-YL]-ETHANONE

1-FURAN-2-YL-2-[2-(2-HYDROXY-ETHYLAMINO)-BENZOIMIDAZOL-1-YL]-ETHANONE

C15H15N3O3 (285.1113)


   

2-CHLORO-N-[2-(3,4-DIETHOXY-PHENYL)-ETHYL]-ACETAMIDE

2-CHLORO-N-[2-(3,4-DIETHOXY-PHENYL)-ETHYL]-ACETAMIDE

C14H20ClNO3 (285.1132)


   

(4-((4-METHOXYBENZYL)CARBAMOYL)PHENYL)BORONIC ACID

(4-((4-METHOXYBENZYL)CARBAMOYL)PHENYL)BORONIC ACID

C15H16BNO4 (285.1172)


   
   

N-(2-phenylphenyl)-1H-benzimidazol-2-amine

N-(2-phenylphenyl)-1H-benzimidazol-2-amine

C19H15N3 (285.1266)


   

4-(2-PIPERIDINOETHOXY)BENZOIC ACID HYDROCHLORIDE

4-(2-PIPERIDINOETHOXY)BENZOIC ACID HYDROCHLORIDE

C14H20ClNO3 (285.1132)


   

BOC-D,L-5,5,5-TRIFLUOROLEUCINE

BOC-D,L-5,5,5-TRIFLUOROLEUCINE

C11H18F3NO4 (285.1188)


   

(2-Methyl-1H-indol-3-yl)(1-naphthyl)methanone

(2-Methyl-1H-indol-3-yl)(1-naphthyl)methanone

C20H15NO (285.1154)


   

METHYL 5-OXO-6-(PYRIDIN-2-YLAMINO)-1,2,3,5-TETRAHYDROINDOLIZINE-8-CARBOXYLATE

METHYL 5-OXO-6-(PYRIDIN-2-YLAMINO)-1,2,3,5-TETRAHYDROINDOLIZINE-8-CARBOXYLATE

C15H15N3O3 (285.1113)


   

2-Chloro-6-(trifluoromethyl)nicotinonitrile

2-Chloro-6-(trifluoromethyl)nicotinonitrile

C15H15N3O3 (285.1113)


   

(3-((4-Methoxybenzyl)carbamoyl)phenyl)boronic acid

(3-((4-Methoxybenzyl)carbamoyl)phenyl)boronic acid

C15H16BNO4 (285.1172)


   

(+)-PD 128,907 HCl

(+)-PD 128,907 HCl

C14H20ClNO3 (285.1132)


(+)-PD 128907 hydrochloride is a selective dopamine D2/D3 receptor agonist, with Kis of 1.7, 0.84 nM for human and rat D3 receptors, 179, 770 n M for human and rat D3 receptors, respectively.

   

n,o-bis(diethylhydrogensilyl)trifluoroacetamide

n,o-bis(diethylhydrogensilyl)trifluoroacetamide

C10H22F3NOSi2 (285.1192)


   

1H-Pyrrolo[2,3-b]pyridin-6-amine, 2,3-diphenyl-

1H-Pyrrolo[2,3-b]pyridin-6-amine, 2,3-diphenyl-

C19H15N3 (285.1266)


   
   

1H-Benz[g]indole-3-carboxaldehyde,2-(2-methylphenyl)-(9CI)

1H-Benz[g]indole-3-carboxaldehyde,2-(2-methylphenyl)-(9CI)

C20H15NO (285.1154)


   

n-(3-n-butoxy-2-hydroxypropyl)iminodiacetic acid monosodium salt

n-(3-n-butoxy-2-hydroxypropyl)iminodiacetic acid monosodium salt

C11H20NNaO6 (285.1188)


   

3,8-DIAMINO-6-PHENYLPHENANTHRIDINE

3,8-DIAMINO-6-PHENYLPHENANTHRIDINE

C19H15N3 (285.1266)


   

Benzyl 4-hydrazinylpiperidine-1-carboxylate hydrochloride

Benzyl 4-hydrazinylpiperidine-1-carboxylate hydrochloride

C13H20ClN3O2 (285.1244)


   

4-[2-(1-Pipiridine)ethoxybenzoic acid hydrochloride

4-[2-(1-Pipiridine)ethoxybenzoic acid hydrochloride

C14H20ClNO3 (285.1132)


   

(2S)-2-Amino-4-methyl-1-[(2S)-2-methyl-2-oxiranyl]-1-pentanone trifluoroacetate (1:1)

(2S)-2-Amino-4-methyl-1-[(2S)-2-methyl-2-oxiranyl]-1-pentanone trifluoroacetate (1:1)

C11H18F3NO4 (285.1188)


   

N-octyl-4-metylpyridinium bromide

N-octyl-4-metylpyridinium bromide

C14H24BrN (285.1092)


   

Methyl N-(2-pyrazinylcarbonyl)phenylalaninate

Methyl N-(2-pyrazinylcarbonyl)phenylalaninate

C15H15N3O3 (285.1113)


   

Benzyl (1-(4-fluorophenyl)cyclopropyl)carbamate

Benzyl (1-(4-fluorophenyl)cyclopropyl)carbamate

C17H16FNO2 (285.1165)


   

2-Methyl-1,3-di-4-pyridylisoindole

2-Methyl-1,3-di-4-pyridylisoindole

C19H15N3 (285.1266)


   

2-(4-((2-Aminophenyl)sulfonyl)piperazin-1-yl)ethanol

2-(4-((2-Aminophenyl)sulfonyl)piperazin-1-yl)ethanol

C12H19N3O3S (285.1147)


   

N-octyl-3-metylpyridinium bromide

N-octyl-3-metylpyridinium bromide

C14H24BrN (285.1092)


   

(2S)-2-Amino-4-methyl-1-[(2R)-2-methyloxiranyl]-1-pentanone trifluoroacetate

(2S)-2-Amino-4-methyl-1-[(2R)-2-methyloxiranyl]-1-pentanone trifluoroacetate

C11H18F3NO4 (285.1188)


   
   

3-(Boc-amino)-3-(4-chlorophenyl)-1-propanol

3-(Boc-amino)-3-(4-chlorophenyl)-1-propanol

C14H20ClNO3 (285.1132)


   

2-(3-(Diallylamino)propionyl)benzothiophene

2-(3-(Diallylamino)propionyl)benzothiophene

C17H19NOS (285.1187)


   

5-(N-Methyl-N-propyl)amiloride

5-(N-Methyl-N-propyl)amiloride

C10H16ClN7O (285.1105)


   

9-Carbazolyl-(4-methylphenyl)methanone

9-Carbazolyl-(4-methylphenyl)methanone

C20H15NO (285.1154)


   

4-N-hydroxy-1-N-(2-pyridin-4-ylethyl)benzene-1,4-dicarboxamide

4-N-hydroxy-1-N-(2-pyridin-4-ylethyl)benzene-1,4-dicarboxamide

C15H15N3O3 (285.1113)


   

4-[(Cyclopropylethynyl)oxy]-6-fluoro-3-isopropylquinolin-2(1H)-one

4-[(Cyclopropylethynyl)oxy]-6-fluoro-3-isopropylquinolin-2(1H)-one

C17H16FNO2 (285.1165)


   

Coformycin(1+)

Coformycin(1+)

C11H17N4O5+ (285.1199)


The conjugate acid of coformycin arising from protonation of the imine nitrogen.

   

dimethylidenebutanedioylcarnitine

dimethylidenebutanedioylcarnitine

C13H19NO6 (285.1212)


   

(2E,4E)-Hexa-2,4-dienedioylcarnitine

(2E,4E)-Hexa-2,4-dienedioylcarnitine

C13H19NO6 (285.1212)


   

2-phenyl-N-[2-(phenylmethylthio)ethyl]acetamide

2-phenyl-N-[2-(phenylmethylthio)ethyl]acetamide

C17H19NOS (285.1187)


   

N-[(2-methylphenyl)methyl]-2-[(4-methylphenyl)thio]acetamide

N-[(2-methylphenyl)methyl]-2-[(4-methylphenyl)thio]acetamide

C17H19NOS (285.1187)


   

1-(3,4-dihydro-1H-isoquinolin-2-yl)-2-(2-fluorophenoxy)ethanone

1-(3,4-dihydro-1H-isoquinolin-2-yl)-2-(2-fluorophenoxy)ethanone

C17H16FNO2 (285.1165)


   

2-Methyl-3,7-diphenylpyrazolo[1,5-a]pyrimidine

2-Methyl-3,7-diphenylpyrazolo[1,5-a]pyrimidine

C19H15N3 (285.1266)


   

2-(2-Fluorophenyl)-5-(4-methylpiperidin-1-yl)-1,3-oxazole-4-carbonitrile

2-(2-Fluorophenyl)-5-(4-methylpiperidin-1-yl)-1,3-oxazole-4-carbonitrile

C16H16FN3O (285.1277)


   

N-(8-carboxy-3-oxooctanoyl)-L-homoserine lactone

N-(8-carboxy-3-oxooctanoyl)-L-homoserine lactone

C13H19NO6 (285.1212)


   

2-methylpropanoic acid [3-(1H-benzimidazol-2-yl)-3-cyano-2-oxopropyl] ester

2-methylpropanoic acid [3-(1H-benzimidazol-2-yl)-3-cyano-2-oxopropyl] ester

C15H15N3O3 (285.1113)


   

2-[[(2R)-2-formamido-3-hydroxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[(2R)-2-formamido-3-hydroxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C9H22N2O6P+ (285.1215)


   

(2s,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl 2,4-dimethyl-1h-pyrrole-3-carboxylate

(2s,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl 2,4-dimethyl-1h-pyrrole-3-carboxylate

C13H19NO6 (285.1212)


   

3,4,5-trihydroxy-6-methyloxan-2-yl 2,4-dimethyl-1h-pyrrole-3-carboxylate

3,4,5-trihydroxy-6-methyloxan-2-yl 2,4-dimethyl-1h-pyrrole-3-carboxylate

C13H19NO6 (285.1212)


   

3-{3h,4h,9h-pyrido[3,4-b]indol-1-yl}-1h-indole

3-{3h,4h,9h-pyrido[3,4-b]indol-1-yl}-1h-indole

C19H15N3 (285.1266)